Effect of von Willebrand factor and its proteolytic fragments on kinetics of interaction between the light and heavy chains of human factor VIII

Thrombosis Research

Volumn 96, Issue 5, 1999, Pages 343-354

  Saenko, Evgueni L ^a   Loster, K ^b   Josic, D ^c   Sarafanov, Andrei G ^a  

^a HOLLAND LABORATORY   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Octapharma Pharmazeutika Produktions GmbH   (Austria)

Author keywords

Factor VIII; Kinetics; Reconstitution; Subunits; von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ARTICLE; BINDING SITE; BIOSENSOR; BLOOD CLOTTING; HUMAN; KINETICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SURFACE PLASMON RESONANCE;

BINDING SITES; CALCIUM; DIMERIZATION; FACTOR VIII; HUMANS; KINETICS; MANGANESE; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; VON WILLEBRAND FACTOR;

EID: 0032763623     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00123-1     Document Type: Article

References (40)

1. van Dieijen G., Tans G., Rosing J., Hemker H.C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem. 256:1981;3433-3442.
2. Vehar G.A., Keyt B., Eaton D., Rodrigues H., O'Brien D.P., Rotblat F., Opperman H., Keck R., Wood W.I., Harkins R.N., Tuddenham E.G.D., Lawn R.M., Capon D.J. Structure of human factor VIII. Nature. 312:1984;337-340.
3. Fay P.J., Anderson M.T., Chavin S.I., Marder V.J. The size of human factor VIII heterodimers and the effects produced by thrombin. Biochem Biophys Acta. 87:1986;268-278.
4. Fay P.J. Reconstition of human factor VIII from isolated subunits. Arch Biochem Biophys. 262:1988;525-531.
5. Nordfang O., Ezban M. Generation of active coagulation factor VIII from isolated subunits. J.Biol.Chem. 263:1988;1115-1118.
6. Wise R.J., Dorner A.J., Krane M., Pittman D.D., Kaufman R.J. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem. 266:1991;21948-21955.
7. Fay P.J., Coumans J.-V., Walker F.J. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem. 266:1991;2172-2177.
8. Nesheim M., Pittman D.D., Giles A.R., Fass D.N., Wang J.H., Slonosky D., Kaufman R.I. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem. 266:1991;17815-17826.
9. Koppelman S.J., Koedam J.A., van Wijnen M., Stern D.M., Nawroth P.P., Sixma J.J., Bouma B.N. von Willebrand factor as a regulator of intrinsic factor X activation. J Lab Clin Med. 123:1994;585-593.
10. Foster P.A., Fulcher C.A., Marti T., Titani K., Zimmerman T.S. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem. 262:1987;8443-8446.
11. Bahou W.F., Ginsburg D., Sikkink R., Litwiller R., Fass D.N. A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide. J Clin Invest. 84:1989;56-61.
12. Jorieux S., Gaucher C., Pietu G., Cherel C., Meyer D., Mazurier C. Fine epitope mapping of monoclonal antibodies to NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides. Interest for the localization of the factor VIII binding domain Br J Haematol. 87:1994;113-118.
13. Lollar P., Parker C.G. Stoichiometry of the porcine factor VIII-von Willebrand factor association. J Biol Chem. 262:1987;17572-17576.
14. Vlot A.J., Koppelman S.J., van den Berg M.H., Bouma B.N., Sixma J.J. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood. 85:1995;3150-3157.
15. Lollar P., Hill-Eubanks D.C., Parker C.G. Association of the factor VIII light chain with von Willebrand factor. J Biol Chem. 263:1988;10451-10455.
16. Foster P.A., Fulcher C.A., Houghten R.A., Zimmerman T.S. An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem. 263:1988;5230-5234.
17. Saenko E.L., Scandella D. The acidic region of the light chain and the C2 domain together form a high affinity binding site for von Willebrand factor. J Biol Chem. 272:1997;18007-18014.
18. Saenko E.L., Shima M., Rajalakshmi K.J., Scandella D. A role for the C2 domain of factor VIII in binding to von Willebrand factor. J Biol Chem. 269:1994;11601-11605.
19. Saenko E.L., Scandella D. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor. J Biol Chem. 270:1995;13826-13833.
20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
21. Lollar P., Parker C.G., Tracy R.P. Molecular characterization of commercial porcine factor VIII concentrate. Blood. 71:1988;137-143.
22. Chopek M.W., Girma J.-P., Fujikawa K., Davie E.W., Titani K. Human von Willebrand factor. A multivalent protein composed of identical subunits Biochemistry. 25:1986;3146-3155.
23. Girma J.-P., Chopek M.W., Titani K., Davie E.W. Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease. Isolation and partial characterization of platelet-binding domain Biochemistry. 25:1986;3156-3163.
24. Marti T., Rosselet S.J., Titani K., Walsh K.A. Identification of disulfide-bridged substractures within human von Willebrand factor. Biochemistry. 26:1987;8099-8109.
25. Lollar P., Fay P.J., Fass D.N. Factor VIII and factor VIIIa. Methods Enzymol. 222:1993;128-143.
26. Regan L.M., Fay P.J. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity. J Biol Chem. 270:1995;8546-8552.
27. Bowie EJW, Owen CA. Ratnoff OD, Forbes CD, editors. Disorders of hemostasis. Orlando, FL: Grune & Startton, Inc.; 1984. p. 43-72.
28. Sudhakar K., Fay P.J. Effects of copper on the structure and function of factor VIII subunits. Evidence for an auxiliary role for copper ions in cofactor activity Biochemistry. 37:1998;6874-6882.
29. Saenko E.L., Shima M., Gilbert G.E., Scandella D. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem. 271:1996;27424-27431.
30. Fay P.J., Haidaris P.J., Smudzin T.M. Human factor VIIIa subunit structure. Reconstitution of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem. 266:1991;8957-8962.
31. Hoyer L.W., Trabold N.C. Immunoradiometric assays for factor VIII antigens. Coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor) Methods Enzymol. 84:1982;51-60.
32. Titani K., Kumar S., Takio K., Ericsson L.H., Wade R.D., Ashida K., Walsh K.A., Chopek M.W., Dadler J.E., Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry. 25:1986;3171-3184.
33. Fay P.J., Smudzin T.M. Topography of the human factor VIII-von Willebrand factor complex. J Biol Chem. 265:1990;6197-6202.
34. Johnsson B., Lofas S., Lindquist G. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction anlysis in surface plasmon resonance sensors. Anal Biochem. 198:1991;268-277.
35. O'Shannessy D.J., Brigham-Burke M., Sonenson K.K., Hensley P., Brooks I. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance. Use of nonlinear least squares analysis methods Anal Biochem. 212:1993;457-468.
36. Donath M.-J.S.H., Lenting P.J., van Mourik J.A., Mertens K. The role of cleavage of the light chain at positions arg1689 or arg1721 in subunit interaction and activation of human blood coagulation factor VIII. J Biol Chem. 270:1996;3648-3655.
37. Bihoreau N., Pin S., de Kersabiec A.-M., Vidot F., Fontaine-Aupart M.-P. Copper-atom identification in the active and inactive forms of plasma derived fVIII and recombinant fVIII-deltaII. Eur J Biochem. 220:1994;41-48.
38. Tagliavacca L., Moon N., Dunham W.R., Kaufman R.J. Identification and functional requirement of Cu(I) and its ligands within coagulation factor VIII. J Biol Chem. 272:1997;27428-27434.
39. Fijnvandraat K., Bertorp E., Ten Cate J.W., Johnsson H., Peters M., Savidge G., Tengborn L., Spira J., Stahl C. Recombinant, B-domain deleted Factor VIII (r-VIII SQ). Pharmacokinetics and initial safety aspects in hemophilia A patients Thromb Haemost. 77:1997;298-302.
40. Bjorkman S., Carlsson M., Berntorp E., Stenberg P. Pharmacokinetics of factor VIII in humans. Clin Pharmacokinet. 22:1992;385-395.